# US 2012/0252057 A1 · Method and device for detecting tumorous living cell tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252057 A1
- Document ID: US20120252057A1
- Status: Published application
- Kind: A1
- Application number: 13/320,610
- Filed: 2010-05-12
- Published: 2012-10-04
- Earliest claimed: 2009-05-15
- Assignees: Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V.; Siemens Aktiengesellschaft
- Inventors: Juergen Schrelber; Joerg Opitz; Carola Gerich; Jens Fehre; Georg Salomon; Ralf Nanke
- Web page: https://patentgrep.com/patent/US20120252057A1

## CPC

- G01N 21/6486: {Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence)}
- A61B 5/0059: {using light, e.g. diagnosis by transillumination, diascopy, fluorescence (photoacoustic A61B5/0093; optical measurement of heart rate A61B5/02416; optical measurement of blood flow A61B5/0261; optical measurement of analytes A61B5/1455)}
- G01N 21/6408: {with measurement of decay time, time resolved fluorescence}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The invention relates to a method and to an apparatus for recognizing tumorous living cell tissue. It furthermore relates to a method and to an apparatus for recognizing tumorous cell tissue at collected living cell tissue samples. In the method, electromagnetic radiation is emitted with local definition onto cell tissue by a radiation source and, after deactivation of the radiation source, the decay behavior of the inherent fluorescence intensity of the cell tissue excited by the electromagnetic radiation is detected at the cell tissue in a time resolved and spectrally resolved manner at known sampling rate(s) for at least one wavelength using a detector. The difference autocorrelation function C(t) of the intensity decay behavior is determined using the determined measured intensity values, the fractal dimension DF for the respective irradiated cell tissue is calculated from this and the value of the fractal dimension DF is used for a classification with respect to a presence of a tumor in the respective irradiated cell tissue.

## Claims

### Claim 1

A method for recognizing tumorous living cell tissue, wherein electromagnetic radiation is emitted in a locally defined manner onto cell tissue by a radiation source and, after a deactivation of the radiation source, the decay behavior of the inherent fluorescence intensity of the cell tissue excited by the electromagnetic radiation is detected with time and spectral resolution using known sampling rate(s) for at least one wavelength using a detector; and
the difference autocorrelation function C(t) of the intensity decay behavior is determined using the determined measured intensity values, the fractal dimension DF is calculated for the respective irradiated cell tissue and
the value of the fractal dimension DF is used for a classification with respect to a presence of a tumor in the respective irradiated cell tissue.

### Claim 2

A method for recognizing tumorous cell tissue at collected living cell tissue samples, wherein, using a radiation source,
electromagnetic radiation is emitted in a locally defined manner onto a cell tissue sample and, after a deactivation of the radiation source, the decay behavior of the inherent fluorescence intensity of the cell tissue excited by the electromagnetic radiation is detected at the cell tissue with a detector in a time resolved and spectrally resolved manner at known sampling rate(s) for at least one wavelength, and
the difference autocorrelation function C(t) of the intensity decay behavior is determined using the determined measured intensity values, the fractal dimension DF is calculated for the respective irradiated cell tissue and
the value of the fractal dimension DF is used for a classification with respect to a presence of a tumor in the respective irradiated cell tissue.

### Claim 3 (depends on 1)

A method in accordance with claim 1, characterized in that monochromatic electromagnetic radiation is used for the inherent fluorescence excitation of the irradiated cell tissue.

### Claim 4 (depends on 1)

A method in accordance with claim 1, characterized in that the measured intensity values are detected within an interval around a wavelength of the excited inherent fluorescence and the difference autocorrelation function of the intensity decay behavior C(t) of the mean values which were calculated from the fluorescence intensities simultaneously detected for the different wavelengths within the wavelength interval is determined and the fractal dimension DF for the irradiated cell tissue is calculated.

### Claim 5 (depends on 1)

A method in accordance with claim 1, characterized in that detection is carried out at a constant sampling rate.

### Claim 6 (depends on 1)

A method in accordance with claim 1, characterized in that the detection is carried out using a spectrometer and detection is performed at a sampling rate ≦1000 ps.

### Claim 7 (depends on 1)

A method in accordance with claim 1, characterized in that the irradiation and detection are carried out in an optically non-transparent chamber.

### Claim 8 (depends on 1)

A method in accordance with claim 1, characterized in that monochromatic radiation having a wavelength of 337 nm is used for the excitation of the inherent fluorescence and the detection is carried out within a wavelength interval of 421.7 nm±15 nm.

### Claim 9 (depends on 1)

A method in accordance with claim 1, characterized in that at least 30 wavelengths from the wavelength interval are considered for the averaging.

### Claim 10 (depends on 1)

A method in accordance with claim 1, characterized in that the electromagnetic radiation for the excitation of the inherent fluorescence is directed to the cell tissue via at least one optical fiber and the inherent fluorescent light is directed to the detector via the same optical fiber(s) after the deactivation of the radiation source.

### Claim 11 (depends on 1)

A method in accordance with claim 1, characterized in that the cell tissue sample to be detected is cooled before and during the detection and is maintained at a constant temperature in so doing.

### Claim 12 (depends on 1)

A method in accordance with claim 1, characterized in that prostate cell tissue is used for a cell tissue sample.

### Claim 13 (depends on 1)

A method in accordance with claim 1, characterized in that the classification is carried out with respect to a presence of a tumor by a comparison with a threshold value specific to a tumor.

### Claim 14 (depends on 1)

A method in accordance with claim 1, characterized in that the classification with respect to the presence of a tumor takes place by an indication of a probability for a presence of a tumor.

### Claim 15 (depends on 1)

An apparatus for carrying out the method in accordance with claim 1, wherein electromagnetic radiation of a radiation source is directed in a locally defined manner to cell tissue and a detector for detecting the inherent fluorescence intensity of the cell tissue in a time resolved and spectrally resolved manner is connected to an electronic evaluation unit with which the difference autocorrelation function C(t) can be determined from the determined measured intensity values, the fractal dimension DF can be calculated therefrom and the value of the fractal dimension DF can be compared with a threshold value typical for a tumor.
